Target RNA modification for epigenetic drug repositioning in neuroblastoma: computational omics proximity between repurposing drug and disease
Structures for different kinds of inhibitors. (A) The structure of 7 overlapped drugs in CMap and L1000FWD. (B) Core structures for HDAC inhibitors. (C) Core structures for topoisomerase inhibitors. (D) Core structures for kinase inhibitors.